CRISPR-based diagnostics offer transformative solutions for disease detection, utilizing advanced gene-editing tools for precise and rapid molecular testing.

CRISPR-based technologies have taken the world by storm thanks to the technique’s ability to edit nucleic acids. Today, researchers are not only working to understand how to better harness the ...

Repurposing native CRISPR systems To engineer microbes within the microbiome, scientists can leverage an existing CRISPR system, an approach that Barrangou has been exploring for more than a decade.

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic research and therapeutic applications.

Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this revolution is CRISPR Therapeutics.

CHICAGO, IL—A novel CRISPR/Cas-9-based gene-editing technique seems to safely diminish the production of a protein linked to worsening outcomes in patients with transthyretin (ATTR) amyloidosis ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...

Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.

The enzyme, called "CRISPR-associated protein 9," or Cas9, is essentially a pair of molecular scissors. There are also other types of Cas enzymes that can be utilized in gene editing.

Scientists are continuing to refine CRISPR techniques to enhance precision, reduce off-target effects and expand its applications beyond DNA editing. This infographic explores the history, ...

CRISPR is focused on developing gene-based medicines using CRISPR and Cas9 technologies. See here if CRSP stock could be a powerful addition to your portfolio.

ICER identifies a justifiable price point of up to $1.9 million for upcoming sickle cell disease treatments, Exa-cel and Lovo-cel. Read more here.